LifeQ collaborates with B-Secur to develop Electrocardiogram technology solution.
According to an announcement from the company, B-Secur’s Electrocardiogram (EKG/ECG) technology will be integrated into LifeQ’s optical PPG (photoplethysmography) technology to enable advanced identification, wellness and health monitoring features in the next generation of everyday devices.
LifeQ revealed that its PPG signal conditioning technologies are used by leading technology companies to boost accuracy for use in business and clinical applications.
CEO of LifeQ, Laurie Olivier said, “With technology advancement and the increasing quest to improve health and wellbeing, whether to consumers, employees, employers, and even governments, the global biosensing market has grown exponentially in recent years.”
“Events such as COVID-19 have further highlighted the importance of real-time health monitoring and, specifically to make this available to everyone. We are thrilled that our partnership with B-Secur allows us to accelerate our goal of improving wellbeing and reducing the cost of good health for all in conjunction with some of the world’s leading technology companies,” Laurie added.
Furthermore, the CEO of B-Secur said, “Many of the technology features that are on offer through an integrated B-Secur and LifeQ solution are currently only accessible in medical environments or by the fortunate few. Today’s announcement will accelerate access to this type of information to everyone. We are very fortunate to find a partner in LifeQ that shares a common goal and we are confident that together we provide class-beating technologies.”
The collaboration is expected to speed up the integration, launch, and adoption of high-performance biosensing solutions for safe health and wellness features in smartwatches and other fitness trackers.
LifeQ was founded in 2014 in South Africa while B-Secur was founded in 2014 in Belfast, United Kingdom.